Your browser doesn't support javascript.
loading
Attenuating ribosome load improves protein output from mRNA by limiting translation-dependent mRNA decay.
Bicknell, Alicia A; Reid, David W; Licata, Marissa C; Jones, Adriana K; Cheng, Yi Min; Li, Mengying; Hsiao, Chiaowen Joyce; Pepin, Christopher S; Metkar, Mihir; Levdansky, Yevgen; Fritz, Brian R; Andrianova, Elizaveta A; Jain, Ruchi; Valkov, Eugene; Köhrer, Caroline; Moore, Melissa J.
Affiliation
  • Bicknell AA; Moderna, Inc, 325 Binney Street, Cambridge, MA 02142, USA. Electronic address: alicia.bicknell@modernatx.com.
  • Reid DW; Moderna, Inc, 325 Binney Street, Cambridge, MA 02142, USA.
  • Licata MC; Moderna, Inc, 325 Binney Street, Cambridge, MA 02142, USA.
  • Jones AK; Moderna, Inc, 325 Binney Street, Cambridge, MA 02142, USA.
  • Cheng YM; Moderna, Inc, 325 Binney Street, Cambridge, MA 02142, USA.
  • Li M; Moderna, Inc, 325 Binney Street, Cambridge, MA 02142, USA.
  • Hsiao CJ; Moderna, Inc, 325 Binney Street, Cambridge, MA 02142, USA.
  • Pepin CS; Moderna, Inc, 325 Binney Street, Cambridge, MA 02142, USA.
  • Metkar M; Moderna, Inc, 325 Binney Street, Cambridge, MA 02142, USA.
  • Levdansky Y; RNA Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.
  • Fritz BR; Moderna, Inc, 325 Binney Street, Cambridge, MA 02142, USA.
  • Andrianova EA; Moderna, Inc, 325 Binney Street, Cambridge, MA 02142, USA.
  • Jain R; Moderna, Inc, 325 Binney Street, Cambridge, MA 02142, USA.
  • Valkov E; RNA Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.
  • Köhrer C; Moderna, Inc, 325 Binney Street, Cambridge, MA 02142, USA.
  • Moore MJ; Moderna, Inc, 325 Binney Street, Cambridge, MA 02142, USA. Electronic address: melissa.moore@modernatx.com.
Cell Rep ; 43(4): 114098, 2024 Apr 23.
Article in En | MEDLINE | ID: mdl-38625793
ABSTRACT
Developing an effective mRNA therapeutic often requires maximizing protein output per delivered mRNA molecule. We previously found that coding sequence (CDS) design can substantially affect protein output, with mRNA variants containing more optimal codons and higher secondary structure yielding the highest protein outputs due to their slow rates of mRNA decay. Here, we demonstrate that CDS-dependent differences in translation initiation and elongation rates lead to differences in translation- and deadenylation-dependent mRNA decay rates, thus explaining the effect of CDS on mRNA half-life. Surprisingly, the most stable and highest-expressing mRNAs in our test set have modest initiation/elongation rates and ribosome loads, leading to minimal translation-dependent mRNA decay. These findings are of potential interest for optimization of protein output from therapeutic mRNAs, which may be achieved by attenuating rather than maximizing ribosome load.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ribosomes / Protein Biosynthesis / RNA, Messenger / RNA Stability Limits: Humans Language: En Journal: Cell Rep Year: 2024 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ribosomes / Protein Biosynthesis / RNA, Messenger / RNA Stability Limits: Humans Language: En Journal: Cell Rep Year: 2024 Type: Article